AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 10539706 — intervention group
Group type: EXPERIMENTAL
Intervention: Spira Ultra ultrasonic nebulizer with budesonide (0.5 mg)
Number of subjects: 10
Study 10539706 — intervention group
Group type: EXPERIMENTAL
Intervention: Spira Elektro 4 jet nebulizer with terbutaline (5.0 mg)
Number of subjects: 10
Study 10539706 — intervention group
Group type: EXPERIMENTAL
Intervention: Spira Ultra ultrasonic nebulizer with terbutaline (5.0 mg)
Number of subjects: 10
Study 8800583 — intervention group
Group type: EXPERIMENTAL
Intervention: Atenolol
Number of subjects: 23
Study 8800583 — intervention group
Group type: COMPARATOR
Intervention: Celiprolol
Number of subjects: 23
Study 8800583 — intervention group
Group type: COMPARATOR
Intervention: Doxazosin
Number of subjects: 23
Study 8800583 — intervention group
Group type: COMPARATOR
Intervention: Enalapril
Number of subjects: 23
Study 8800583 — intervention group
Group type: COMPARATOR
Intervention: Nifedipine
Number of subjects: 23
Study 1863505 — intervention group
Group type: EXPERIMENTAL
Intervention: iopentol
Number of subjects: 61
Study 1863505 — intervention group
Group type: COMPARATOR
Intervention: iohexol
Number of subjects: 61
Study 6846920 — intervention group
Group type: EXPERIMENTAL
Intervention: Albuterol (100 and 200 micrograms)
Number of subjects: 11
Study 6846920 — intervention group
Group type: COMPARATOR
Intervention: Isoproterenol (70 and 140 micrograms)
Number of subjects: 11
Study 6846920 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 11
Study 31416352 — intervention group
Group type: EXPERIMENTAL
Intervention: Non-native Norwegian speakers
Number of subjects: 238
Study 31416352 — intervention group
Group type: COMPARATOR
Intervention: Native Norwegian speakers
Number of subjects: 238
Study 29766403 — intervention group
Group type: EXPERIMENTAL
Intervention: Teacher involvement (measured through teacher-reports)
Number of subjects: 570
Study 29766403 — intervention group
Group type: EXPERIMENTAL
Intervention: Depressive symptoms (measured through peer- and teacher-reports)
Number of subjects: 570
Study 30255204 — intervention group
Group type: EXPERIMENTAL
Intervention: Posterior pillar mucosal suspension technique (Group A)
Number of subjects: 121
Study 30255204 — intervention group
Group type: COMPARATOR
Intervention: Bipolar cautery (Group B)
Number of subjects: 121
Study 30255204 — intervention group
Group type: COMPARATOR
Intervention: Cold dissection tonsillectomy (Group C)
Number of subjects: 121
Study 27169809 — intervention group
Group type: EXPERIMENTAL
Intervention: Goal-setting + self-monitoring + feedback (GS + SM + F, n = 40)
Number of subjects: 124
Study 27169809 — intervention group
Group type: EXPERIMENTAL
Intervention: Goal-setting + self-monitoring (GS + SM, n = 40)
Number of subjects: 124
Study 27169809 — intervention group
Group type: COMPARATOR
Intervention: Goal-setting only (GS, n = 44)
Number of subjects: 124
Study 24722045 — intervention group
Group type: EXPERIMENTAL
Intervention: Family Intervention: Telephone Tracking
Number of subjects: 49
Study 24722045 — intervention group
Group type: COMPARATOR
Intervention: Treatment as usual
Number of subjects: 49
Study 22318834 — intervention group
Group type: EXPERIMENTAL
Intervention: Fentanyl plus ketamine (Group FK)
Number of subjects: 60
Study 22318834 — intervention group
Group type: COMPARATOR
Intervention: Fentanyl (Group F)
Number of subjects: 60
Study 22318834 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 60
Study 18823336 — intervention group
Group type: EXPERIMENTAL
Intervention: Glibenclamide
Number of subjects: 14
Study 18823336 — intervention group
Group type: EXPERIMENTAL
Intervention: Diclofenac
Number of subjects: 14
Study 18823336 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination of glibenclamide and diclofenac
Number of subjects: 14
Study 18823336 — intervention group
Group type: COMPARATOR
Intervention: Saline solution
Number of subjects: 14
Study 17155990 — intervention group
Group type: EXPERIMENTAL
Intervention: Neoadjuvant hormone therapy (HT)
Number of subjects: 316
Study 15819758 — intervention group
Group type: EXPERIMENTAL
Intervention: Imitation
Number of subjects: 0
Study 15819758 — intervention group
Group type: COMPARATOR
Intervention: Viewing presentation of events
Number of subjects: 0
Study 12111907 — intervention group
Group type: EXPERIMENTAL
Intervention: Not available
Number of subjects: 0
Study 9506874 — intervention group
Group type: EXPERIMENTAL
Intervention: CPH-82 (Reumacon)
Number of subjects: 60
Study 9506874 — intervention group
Group type: COMPARATOR
Intervention: Auranofin (Ridaura)
Number of subjects: 60
Study 7825428 — intervention group
Group type: EXPERIMENTAL
Intervention: Contralateral acoustic stimulation
Number of subjects: 2
Study 7825428 — intervention group
Group type: COMPARATOR
Intervention: No contralateral noise (baseline)
Number of subjects: 2
Study 3137605 — intervention group
Group type: EXPERIMENTAL
Intervention: DL-threo-3,4-dihydroxyphenylserine (DOPS) 1 g dose
Number of subjects: 0
Study 3137605 — intervention group
Group type: COMPARATOR
Intervention: Placebo (lactose)
Number of subjects: 0
Study 30131330 — intervention group
Group type: EXPERIMENTAL
Intervention: '11+ Kids' injury prevention programme
Number of subjects: 1002
Study 30131330 — intervention group
Group type: COMPARATOR
Intervention: Usual warmup
Number of subjects: 1002
Study 30131330 — intervention group
Group type: EXPERIMENTAL
Intervention: Countrywide implementation of '11+ Kids'
Number of subjects: 1002
Study 29675430 — intervention group
Group type: EXPERIMENTAL
Intervention: PFD + M-DDO
Number of subjects: 0
Study 29675430 — intervention group
Group type: COMPARATOR
Intervention: Ketanserin
Number of subjects: 0
Study 25989386 — intervention group
Group type: EXPERIMENTAL
Intervention: Small covered transjugular intrahepatic portosystemic stent-shunt (TIPS) (8 mm; n = 90)
Number of subjects: 185
Study 25989386 — intervention group
Group type: COMPARATOR
Intervention: Medical reduction of portal pressure (propranolol and isosorbide-5-mononitrate; n = 95)
Number of subjects: 185
Study 25989386 — intervention group
Group type: COMPARATOR
Intervention: Medical treatment before hemodynamic control
Number of subjects: 185
Study 25989386 — intervention group
Group type: COMPARATOR
Intervention: Responders to medical treatment
Number of subjects: 185
Study 25989386 — intervention group
Group type: COMPARATOR
Intervention: Nonresponders to medical treatment (variceal band ligation)
Number of subjects: 185
Study 25989386 — intervention group
Group type: COMPARATOR
Intervention: TIPS placement during follow-up evaluation
Number of subjects: 185
Study 25989386 — intervention group
Group type: EXPERIMENTAL
Intervention: TIPS and medical treatment
Number of subjects: 185
Study 25989386 — intervention group
Group type: EXPERIMENTAL
Intervention: TIPS
Number of subjects: 185
Study 23577819 — intervention group
Group type: EXPERIMENTAL
Intervention: Anterior ultrasound-guided superior hypogastric plexus neurolysis
Number of subjects: 50
Study 23577819 — intervention group
Group type: COMPARATOR
Intervention: Oral morphine
Number of subjects: 50
Study 21160196 — intervention group
Group type: EXPERIMENTAL
Intervention: Droperidol (2.5 mg)
Number of subjects: 100
Study 21160196 — intervention group
Group type: EXPERIMENTAL
Intervention: Metoclopramide (10 mg)
Number of subjects: 100
Study 21160196 — intervention group
Group type: EXPERIMENTAL
Intervention: Tropisetron (2.5 mg)
Number of subjects: 100
Study 21160196 — intervention group
Group type: EXPERIMENTAL
Intervention: Ondansetron (4 mg)
Number of subjects: 100
Study 21160196 — intervention group
Group type: COMPARATOR
Intervention: Control (no prophylactic antiemetic treatment)
Number of subjects: 100
Study 21160196 — intervention group
Group type: EXPERIMENTAL
Intervention: Droperidol
Number of subjects: 100
Study 21160196 — intervention group
Group type: EXPERIMENTAL
Intervention: Tropisetron
Number of subjects: 100
Study 21160196 — intervention group
Group type: COMPARATOR
Intervention: Control
Number of subjects: 100
Study 19589122 — intervention group
Group type: EXPERIMENTAL
Intervention: Manidipine 20 mg
Number of subjects: 64
Study 19589122 — intervention group
Group type: COMPARATOR
Intervention: Amlodipine 10 mg
Number of subjects: 64
Study 17575270 — intervention group
Group type: EXPERIMENTAL
Intervention: Risk score predictive of major bleeding after PCI
Number of subjects: 7058
Study 17575270 — intervention group
Group type: EXPERIMENTAL
Intervention: Risk model validation
Number of subjects: 7058
Study 15510018 — intervention group
Group type: EXPERIMENTAL
Intervention: H. pylori antibody testing by ELISA
Number of subjects: 30
Study 15510018 — intervention group
Group type: EXPERIMENTAL
Intervention: Immunohistochemical analysis with H. pylori antibody
Number of subjects: 30
Study 15510018 — intervention group
Group type: COMPARATOR
Intervention: Comparison of H. pylori antibodies by ELISA
Number of subjects: 30
Study 15510018 — intervention group
Group type: COMPARATOR
Intervention: Comparison of biopsy specimens by immunohistochemical staining
Number of subjects: 30
Study 12964220 — intervention group
Group type: EXPERIMENTAL
Intervention: Mepiform Safetac (one 24‐hour application)
Number of subjects: 32
Study 12964220 — intervention group
Group type: EXPERIMENTAL
Intervention: Mepiform Safetac (three x 24‐hour applications)
Number of subjects: 32
Study 12964220 — intervention group
Group type: EXPERIMENTAL
Intervention: Mepilex Border Safetac (three x 24‐hour applications)
Number of subjects: 32
Study 12964220 — intervention group
Group type: EXPERIMENTAL
Intervention: Duoderm Extra Thin (three x 24‐hour applications)
Number of subjects: 32
Study 12964220 — intervention group
Group type: EXPERIMENTAL
Intervention: Allevyn Adhesive (three x 24‐hour applications)
Number of subjects: 32
Study 12964220 — intervention group
Group type: EXPERIMENTAL
Intervention: Biatain Adhesive (three x 24‐hour applications)
Number of subjects: 32
Study 12964220 — intervention group
Group type: EXPERIMENTAL
Intervention: Tielle Hydropolymer Dressing (three x 24‐hour applications)
Number of subjects: 32
Study 9154761 — intervention group
Group type: EXPERIMENTAL
Intervention: MAGE-1 protein detection in gliomas
Number of subjects: 28
Study 9154761 — intervention group
Group type: EXPERIMENTAL
Intervention: MAGE-4 protein detection in gliomas
Number of subjects: 28
Study 9154761 — intervention group
Group type: COMPARATOR
Intervention: MAGE-1 protein detection in non-glioma tumors
Number of subjects: 28
Study 9154761 — intervention group
Group type: COMPARATOR
Intervention: MAGE-4 protein detection in non-glioma tumors
Number of subjects: 28
Study 9154761 — intervention group
Group type: EXPERIMENTAL
Intervention: Cellular MAGE-1 protein detection in glioblastoma cells
Number of subjects: 28
Study 9154761 — intervention group
Group type: EXPERIMENTAL
Intervention: MAGE-4 protein confirmation
Number of subjects: 28
Study 7955262 — intervention group
Group type: EXPERIMENTAL
Intervention: Isradipine (n = 90)
Number of subjects: 177
Study 7955262 — intervention group
Group type: COMPARATOR
Intervention: Sodium nitroprusside (n = 87)
Number of subjects: 177
Study 7955262 — intervention group
Group type: EXPERIMENTAL
Intervention: Isradipine
Number of subjects: 177
Study 7955262 — intervention group
Group type: COMPARATOR
Intervention: Sodium nitroprusside
Number of subjects: 177
Study 7955262 — intervention group
Group type: EXPERIMENTAL
Intervention: Both treatments
Number of subjects: 177
Study 3110819 — intervention group
Group type: EXPERIMENTAL
Intervention: Diazepam
Number of subjects: 12
Study 3110819 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 12
Study 2529048 — intervention group
Group type: EXPERIMENTAL
Intervention: Intranasal sufentanil (15 micrograms)
Number of subjects: 16
Study 2529048 — intervention group
Group type: COMPARATOR
Intervention: Intravenous sufentanil (15 micrograms)
Number of subjects: 16
Study 30394507 — intervention group
Group type: EXPERIMENTAL
Intervention: Atherectomy treatment in diabetic patients (DM)
Number of subjects: 204
Study 30394507 — intervention group
Group type: COMPARATOR
Intervention: Atherectomy treatment in non-diabetic patients (nDM)
Number of subjects: 204
Study 30719850 — intervention group
Group type: EXPERIMENTAL
Intervention: Occlutech Figulla Flex II Occluder (OFFII)
Number of subjects: 176
Study 30719850 — intervention group
Group type: COMPARATOR
Intervention: Amplatzer Septal Occluder (ASO)
Number of subjects: 176
Study 28499022 — intervention group
Group type: EXPERIMENTAL
Intervention: Bevacizumab treatment
Number of subjects: 291
Study 28499022 — intervention group
Group type: EXPERIMENTAL
Intervention: Postcontrast T1-weighted imaging feature (information correlation)
Number of subjects: 291
Study 28499022 — intervention group
Group type: EXPERIMENTAL
Intervention: Postcontrast T1-weighted imaging features
Number of subjects: 291
Study 25555381 — intervention group
Group type: EXPERIMENTAL
Intervention: Intramuscular (IM) administration of Zostavax
Number of subjects: 354
Study 25555381 — intervention group
Group type: COMPARATOR
Intervention: Subcutaneous (SC) administration of Zostavax
Number of subjects: 354
Study 22523117 — intervention group
Group type: EXPERIMENTAL
Intervention: LC-MS/MS method for detection of podocyte-specific tryptic peptides
Number of subjects: 19
Study 25885375 — intervention group
Group type: EXPERIMENTAL
Intervention: Palonosetron
Number of subjects: 60
Study 25885375 — intervention group
Group type: COMPARATOR
Intervention: Palonosetron plus dexamethasone
Number of subjects: 60
Study 19244878 — intervention group
Group type: EXPERIMENTAL
Intervention: rhPDGF‐BB + beta‐TCP + a wound healing dressing
Number of subjects: 6
Study 19244878 — intervention group
Group type: COMPARATOR
Intervention: CTG
Number of subjects: 6
Study 17112693 — intervention group
Group type: EXPERIMENTAL
Intervention: Psidii guajavae folium extract 6 mg/day
Number of subjects: 197
Study 17112693 — intervention group
Group type: EXPERIMENTAL
Intervention: Psidii guajavae folium extract 3 mg/day
Number of subjects: 197
Study 17112693 — intervention group
Group type: COMPARATOR
Intervention: Ibuprofen 1200 mg/day
Number of subjects: 197
Study 17112693 — intervention group
Group type: COMPARATOR
Intervention: Placebo 3 mg/day
Number of subjects: 197
Study 15086613 — intervention group
Group type: EXPERIMENTAL
Intervention: Desensitising toothpaste (SA)
Number of subjects: 6
Study 15086613 — intervention group
Group type: EXPERIMENTAL
Intervention: Non-desensitising toothpaste (F)
Number of subjects: 6
Study 15086613 — intervention group
Group type: EXPERIMENTAL
Intervention: Chlorhexidine mouthwash (CHX)
Number of subjects: 6
Study 15086613 — intervention group
Group type: COMPARATOR
Intervention: No treatment group (P)
Number of subjects: 6
Study 15086613 — intervention group
Group type: EXPERIMENTAL
Intervention: Desensitising toothpaste (SA) with/without OJ
Number of subjects: 6
Study 15086613 — intervention group
Group type: EXPERIMENTAL
Intervention: In-office product (DS)
Number of subjects: 6
Study 15086613 — intervention group
Group type: EXPERIMENTAL
Intervention: Desensitising toothpaste (SC)
Number of subjects: 6
Study 11343004 — intervention group
Group type: EXPERIMENTAL
Intervention: Coronary care‐trained nurse (CCTN) present during ED hours
Number of subjects: 893
Study 11343004 — intervention group
Group type: COMPARATOR
Intervention: No coronary care‐trained nurse (CCTN) present during ED hours
Number of subjects: 893
Study 9562159 — intervention group
Group type: EXPERIMENTAL
Intervention: Resistance exercise (45 minutes of lifting three sets of 10 repetitions at 75% of one repetition maximum)
Number of subjects: 0
Study 9562159 — intervention group
Group type: COMPARATOR
Intervention: Quiet rest (sitting quietly in a room free from distractions)
Number of subjects: 0
Study 8202883 — intervention group
Group type: EXPERIMENTAL
Intervention: Nocturnal asthma patients (n=10)
Number of subjects: 18
Study 8202883 — intervention group
Group type: COMPARATOR
Intervention: Healthy control subjects (n=8)
Number of subjects: 18
Study 3067313 — intervention group
Group type: EXPERIMENTAL
Intervention: Acetazolamide (250 mg 4 times per day)
Number of subjects: 10
Study 3067313 — intervention group
Group type: EXPERIMENTAL
Intervention: Protriptyline (20 mg daily)
Number of subjects: 10
Study 3067313 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 10
Study 29566192 — intervention group
Group type: EXPERIMENTAL
Intervention: Vitamin D intervention (400 IU/d from vitamin D-fortified foods)
Number of subjects: 51
Study 29566192 — intervention group
Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 51
Study 26962834 — intervention group
Group type: EXPERIMENTAL
Intervention: End-stage renal disease (ESRD)
Number of subjects: 1068
Study 26962834 — intervention group
Group type: COMPARATOR
Intervention: Cirrhotic patients without renal function impairment (Control)
Number of subjects: 1068
Study 26962834 — intervention group
Group type: EXPERIMENTAL
Intervention: Cirrhotic patients with ESRD and recurrent complications
Number of subjects: 1068
Study 26962834 — intervention group
Group type: EXPERIMENTAL
Intervention: Cirrhotic patients with ESRD and ascites
Number of subjects: 1068
Study 26962834 — intervention group
Group type: EXPERIMENTAL
Intervention: Cirrhotic patients with ESRD and esophageal variceal bleeding (EVB)
Number of subjects: 1068
Study 26962834 — intervention group
Group type: EXPERIMENTAL
Intervention: Cirrhotic patients with ESRD and hepatic encephalopathy (HE)
Number of subjects: 1068
Study 25330161 — intervention group
Group type: EXPERIMENTAL
Intervention: QuantiFERON-TB Gold In-Tube (QFT-GIT) test
Number of subjects: 975
Study 25330161 — intervention group
Group type: EXPERIMENTAL
Intervention: QFT-GIT test at baseline
Number of subjects: 975
Study 25330161 — intervention group
Group type: EXPERIMENTAL
Intervention: QFT-GIT test at 12 months
Number of subjects: 975
Study 25330161 — intervention group
Group type: COMPARATOR
Intervention: No ART
Number of subjects: 975
Study 25330161 — intervention group
Group type: COMPARATOR
Intervention: IPT and early ART
Number of subjects: 975
Study 22763668 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.65 g/kg alcohol
Number of subjects: 52
Study 22763668 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 52
Study 20032168 — intervention group
Group type: EXPERIMENTAL
Intervention: Lessons in the Alexander Technique
Number of subjects: 359
Study 20032168 — intervention group
Group type: COMPARATOR
Intervention: Exercise prescription
Number of subjects: 359
Study 17011601 — intervention group
Group type: EXPERIMENTAL
Intervention: Frontal brain function and positive symptom schizotypy
Number of subjects: 36
Study 17011601 — intervention group
Group type: EXPERIMENTAL
Intervention: Posterior brain function and low positive affect
Number of subjects: 36
Study 15563538 — intervention group
Group type: EXPERIMENTAL
Intervention: Indomethacin (COX-1 and COX-2 inhibitor)
Number of subjects: 3
Study 15563538 — intervention group
Group type: EXPERIMENTAL
Intervention: Celecoxib (COX-2 inhibitor)
Number of subjects: 3
Study 15563538 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 3
Study 12539211 — intervention group
Group type: EXPERIMENTAL
Intervention: Pramipexole 500 microg
Number of subjects: 10
Study 12539211 — intervention group
Group type: EXPERIMENTAL
Intervention: Pergolide 500 microg
Number of subjects: 10
Study 12539211 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 10
Study 10628188 — intervention group
Group type: EXPERIMENTAL
Intervention: DASH diet (8-10 fruits and vegetables and 2-3 low-fat dairy foods per day)
Number of subjects: 0
Study 10628188 — intervention group
Group type: EXPERIMENTAL
Intervention: DASH diet
Number of subjects: 0
Study 10628188 — intervention group
Group type: COMPARATOR
Intervention: Not available
Number of subjects: 0
Study 8607762 — intervention group
Group type: EXPERIMENTAL
Intervention: Constant angle contract-relax stretch
Number of subjects: 10
Study 8607762 — intervention group
Group type: COMPARATOR
Intervention: Static stretch
Number of subjects: 10
Study 8607762 — intervention group
Group type: EXPERIMENTAL
Intervention: Variable angle contract-relax stretch
Number of subjects: 10
Study 2061535 — intervention group
Group type: EXPERIMENTAL
Intervention: SF-36
Number of subjects: 25
Study 2061535 — intervention group
Group type: COMPARATOR
Intervention: Sickness Impact Profile (SIP)
Number of subjects: 25
Study 7080891 — intervention group
Group type: EXPERIMENTAL
Intervention: Co‐action condition (simultaneous drinking with a heavy drinking accomplice)
Number of subjects: 64
Study 7080891 — intervention group
Group type: COMPARATOR
Intervention: Control observer condition (accomplice completing an art rating task)
Number of subjects: 64
Study 30143028 — intervention group
Group type: EXPERIMENTAL
Intervention: Psychologically supported, patient-centred, multi-disciplinary intervention into frailty
Number of subjects: 50
Study 30143028 — intervention group
Group type: COMPARATOR
Intervention: Usual haemodialysis standard of care
Number of subjects: 50
Study 26871379 — intervention group
Group type: EXPERIMENTAL
Intervention: Swimming intervention (2 times/week, 40-50 minutes for 10 weeks)
Number of subjects: 14
Study 26871379 — intervention group
Group type: EXPERIMENTAL
Intervention: Swimming intervention (after 20-week follow-up)
Number of subjects: 14
Study 26871379 — intervention group
Group type: COMPARATOR
Intervention: Control group (no specific intervention details provided)
Number of subjects: 14
Study 26871379 — intervention group
Group type: EXPERIMENTAL
Intervention: Swimming intervention
Number of subjects: 14
Study 26871379 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 14
Study 24560181 — intervention group
Group type: EXPERIMENTAL
Intervention: Oxygen saturation target of 85%-89%
Number of subjects: 340
Study 24560181 — intervention group
Group type: COMPARATOR
Intervention: Oxygen saturation target of 91%-95%
Number of subjects: 340
Study 21777924 — intervention group
Group type: EXPERIMENTAL
Intervention: Anastrozole (1 mg/d) for 10 days
Number of subjects: 26
Study 21777924 — intervention group
Group type: COMPARATOR
Intervention: No treatment (control)
Number of subjects: 26
Study 20842740 — intervention group
Group type: EXPERIMENTAL
Intervention: Poor R-wave progression (group II, n = 36)
Number of subjects: 70
Study 20842740 — intervention group
Group type: COMPARATOR
Intervention: Normal R-wave progression (group I, n = 34)
Number of subjects: 70
Study 17922972 — intervention group
Group type: EXPERIMENTAL
Intervention: Paclitaxel/carboplatin/gemcitabine (PCG)
Number of subjects: 337
Study 17922972 — intervention group
Group type: COMPARATOR
Intervention: Gemcitabine/vinorelbine
Number of subjects: 337
Study 16320331 — intervention group
Group type: EXPERIMENTAL
Intervention: SELDI-TOF-MS technology for RA patients
Number of subjects: 103
Study 12191852 — intervention group
Group type: EXPERIMENTAL
Intervention: Soy rich diet
Number of subjects: 187
Study 12191852 — intervention group
Group type: EXPERIMENTAL
Intervention: Hormone replacement therapy (HRT)
Number of subjects: 187
Study 12191852 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 187
Study 9700950 — intervention group
Group type: EXPERIMENTAL
Intervention: Wheat amylase inhibitor (WAI) 4 g
Number of subjects: 12
Study 7887719 — intervention group
Group type: EXPERIMENTAL
Intervention: Tepid cardioplegia (29 degrees C)
Number of subjects: 42